Insights into Hepatocellular Carcinoma: From Pathophysiology to Novel Therapies.

Gabbia, Daniela; De Martin, Sara

Gabbia, Daniela; De Martin, Sara.

Afiliação

Gabbia D; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.

Int J Mol Sci ; 25(8)2024 Apr 10.

Article em En | MEDLINE | ID: mdl-38673774

ABSTRACT

ABSTRACT

Hepatocellular carcinoma (HCC), the most common primary liver cancer, accounts for 830,180 related deaths worldwide in 2020, according to GLOBOCAN, representing the fourth leading cause of cancer-related death, with a five-year survival rate of about 18% for advanced stage, and the second leading cause in men of cancer-related mortality worldwide [...].

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Carcinoma Hepatocelular/terapia; Carcinoma Hepatocelular/patologia; Humanos; Neoplasias Hepáticas/patologia; Neoplasias Hepáticas/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google